摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cycloheptyl butyrate

中文名称
——
中文别名
——
英文名称
cycloheptyl butyrate
英文别名
Cycloheptyl butanoate
cycloheptyl butyrate化学式
CAS
——
化学式
C11H20O2
mdl
——
分子量
184.279
InChiKey
GRNSZEZDEODGBP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    环庚醇丁酸silica gel 、 iron(III) perchlorate 作用下, 以 二氯甲烷 为溶剂, 生成 cycloheptyl butyrate
    参考文献:
    名称:
    硅胶上的高氯酸铁为多用途试剂,用于催化环氧,醇和酯中碳-氧键的闭合和断裂
    摘要:
    Aliphatic alcohols and water in the presence of catalytic amounts of Fe3+ ion introduced as iron(Ill) perchlorate on silica gel carrier perform efficient regiospecific opening of an epoxy ring. Carbon acids esterification with various type alcohols was carried out using the system Fe(ClO4)(3)-silica gel in dichloromethane under conditions excluding solvolysis. Acetylation and formylation of alcohols was performed by efficient transesterification with ethyl acetate and ethyl formate.
    DOI:
    10.1023/b:rujo.0000003154.92028.84
点击查看最新优质反应信息

文献信息

  • TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS
    申请人:Goossens Thomas Peter Anne
    公开号:US20130090492A1
    公开(公告)日:2013-04-11
    This invention is directed to a general catalyst of high activity and selectivity for the production of a variety of esters, particularly acrylate and methacrylate-based esters, by a transesterification reaction. This objective is achieved by reaction of an ester of a carboxylic or a carbonic acid, in particular of a saturated or unsaturated, typically, a 3 to 4 carbon atom carboxylic acid; with an alcohol in the presence of a catalyst comprising the combination of a metal 1,3-dicarbonyl complex (pref. Zn or Fe acetylacetonate) and a salt, in particular an inorganic salt, pref. ZnCl2, LiCI, NaCI, NH4CI or Lil. These catalysts are prepared from readily available starting materials within the reaction medium without the need for isolation (in-situ preparation).
    这项发明针对一种高活性和选择性的通用催化剂,用于通过酯交换反应生产各种酯类,特别是丙烯酸酯和甲基丙烯酸酯。该目标通过在存在催化剂的情况下,将羧酸酯或碳酸酯的酯,特别是饱和或不饱和的、通常为3到4个碳原子的羧酸酯;与醇反应来实现。催化剂包括金属1,3-二羰基配合物(首选Zn或Fe乙酰丙酮酸盐)和盐的组合,特别是无机盐,首选ZnCl2,LiCl,NaCl,NH4Cl或I2。这些催化剂是在反应介质中从易得的起始物质制备而成,无需分离(原位制备)。
  • Ruthenium Pincer‐Catalyzed Cross‐Dehydrogenative Coupling of Primary Alcohols with Secondary Alcohols under Neutral Conditions
    作者:Dipankar Srimani、Ekambaram Balaraman、Boopathy Gnanaprakasam、Yehoshoa Ben‐David、David Milstein
    DOI:10.1002/adsc.201200438
    日期:2012.9.17
    Cross‐dehydrogenative coupling of primary alcohols with secondary alcohols to obtain mixed esters with the liberation of molecular hydrogen is achieved in high yield and good selectivity under neutral conditions, using a bipyridyl‐based PNN ruthenium(II) pincer catalyst.
    使用基于联吡啶的PNN钌(II)钳形催化剂,在中性条件下以高收率和良好的选择性实现了伯醇与仲醇的交叉脱氢偶联,以得到混合的酯并释放出分子氢。
  • [EN] NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST<br/>[FR] NOUVEAUX DERIVES DE PYRAZOLE UTILISES COMME ANTAGONISTES DE L'ANGIOTENSINE II
    申请人:J. URIACH & CIA, S.A.
    公开号:WO1996004273A1
    公开(公告)日:1996-02-15
    (EN) Compounds of general formula (I) and their salts and solvates are angiotensin II receptor antagonists and as such are useful in the treatment of hypertension, congestive heat failure and elevated intraocular pressure. Pharmaceutical compositions including these compounds and processes for their preparation are also provided.(FR) Les composés de formule générale (I) (ainsi que leurs sels et solvates) sont des antagonistes du récepteur de l'angiotensine II et à ce titre sont utiles dans le traitement de l'hypertension, de l'insuffisance cardiaque congestive et de l'hypertension intra-oculaire. Des compositions pharmaceutiques renfermant ces composés et des procédés pour leur préparation sont également décrits.
    (中文) 通式 (I) 及其盐和溶剂化合物是血管紧张素 II 受体拮抗剂,因此在治疗高血压、充血性心力衰竭和眼内压升高方面非常有用。还提供了包括这些化合物的药物组合物和其制备方法。
  • LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LUMINESCENT DISPLAY ELEMENT PANEL, AND LUMINESCENT DISPLAY DEVICE
    申请人:TOKYO OHKA KOGYO CO., LTD.
    公开号:EP3812805A1
    公开(公告)日:2021-04-28
    The present invention provides: a liquid composition which can be suitably used for production of an optical film having a favorable fluorescence efficiency and includes quantum dots (A), a quantum dot-containing film obtained by drying and/or curing the liquid composition, an optical film for a light-emitting display element made of the quantum dot-containing film, a light-emitting display element panel including the optical film, and a light-emitting display equipped with the light-emitting display element panel. An ionic liquid (B), and a solvent (S) are incorporated into a liquid composition including quantum dots (A), in which the solvent (S) includes a solvent (S1), the solvent (S1) being a compound having a cyclic skeleton and including a heteroatom other than a hydrogen atom and a carbon atom.
    本发明提供:一种可适当用于生产具有良好荧光效率且包括量子点(A)的光学薄膜的液体组合物、一种通过干燥和/或固化该液体组合物而获得的含量子点薄膜、一种由该含量子点薄膜制成的用于发光显示元件的光学薄膜、一种包括该光学薄膜的发光显示元件面板,以及一种配备有该发光显示元件面板的发光显示器。在包括量子点(A)的液体组合物中加入离子液体(B)和溶剂(S),其中溶剂(S)包括溶剂(S1),溶剂(S1)是具有环状骨架并包括除氢原子和碳原子之外的杂原子的化合物。
  • NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST
    申请人:J. URIACH & CIA. S.A.
    公开号:EP0721454A1
    公开(公告)日:1996-07-17
查看更多